IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2015 Holdings

Filed 2015-05-15 | 17 holdings | $94.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc.(ABBV)COM00287Y109$92.5M1,580,00097.6%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$1.9M31,0002.0%
Ariad Pharmaceuticals IncCOM04033A100$105.9K12,850,0000.1%
Quest Diagnostics Inc(DGX)COM74834L100$59.6K775,0000.1%
Amgen Inc(AMGN)COM031162100$50.8K318,0000.1%
Aegerion Pharmaceuticals IncCOM00767E102$42.9K1,637,4550.0%
Medicines CoCOM584688105$34.0K1,215,1000.0%
Merck & Co Inc New(MRK)COM58933Y105$23.0K400,0000.0%
Flamel Technologies SASPONSORED ADR338488109$15.7K875,0000.0%
Apricus Biosciences IncCOM03832V109$12.2K6,524,5050.0%
Repros Therapeutics IncCOM NEW76028H209$9.7K1,132,3670.0%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$8.6K360,0000.0%
Vivus IncCOM928551100$6.3K2,573,9430.0%
Kindred Biosciences IncCOM494577109$4.9K689,0910.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$3.7K2,570,7590.0%
Targacept IncCOM87611R306$1.9K630,0000.0%
Eleven Biotherapeutics Inc.COM286221106$36841,2000.0%